Literature DB >> 7815493

Structural interactions between retroviral Gag proteins examined by cysteine cross-linking.

M S Hansen1, E Barklis.   

Abstract

We have examined structural interactions between Gag proteins within Moloney murine leukemia virus (M-MuLV) particles by making use of the cysteine-specific cross-linking agents iodine and bis-maleimido hexane. Virion-associated wild-type M-MuLV Pr65Gag proteins in immature particles were intermolecularly cross-linked at cysteines to form Pr65Gag oligomers, from dimers to pentamers or hexamers. Following a systematic approach of cysteine-to-serine mutagenesis, we have shown that cross-linking of Pr65Gag occurred at cysteines of the nucleocapsid (NC) Cys-His motif, suggesting that the Cys-His motifs within virus particles are packed in close proximity. The M-MuLV Pr65Gag protein did not cross-link to the human immunodeficiency virus Pr55Gag protein when the two molecules were coexpressed, indicating either that they did not coassemble or that heterologous Gag proteins were not in close enough proximity to be cross-linked. Using an assembly-competent, protease-minus, cysteine-minus Pr65Gag protein as a template, novel cysteine residues were generated in the M-MuLV capsid domain major homology region (MHR). Cross-linking of proteins containing MHR cysteines showed above-background levels of Gag-Gag dimers but also identified a novel cellular factor, present in virions, that cross-linked to MHR residues. Although the NC cysteine mutation was compatible with M-MuLV particle assembly, deletions of the NC domain were not tolerated. These results suggest that the Cys-His motif is held in close proximity within immature M-MuLV particles by interactions between CA domains and/or non-Cys-His motif domains of the NC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7815493      PMCID: PMC188688     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Point mutations in the P30 domain of the gag gene of Moloney murine leukemia virus.

Authors:  H W Hsu; P Schwartzberg; S P Goff
Journal:  Virology       Date:  1985-04-15       Impact factor: 3.616

2.  Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.

Authors:  R J Gorelick; S M Nigida; J W Bess; L O Arthur; L E Henderson; A Rein
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

3.  Assembly of gag-beta-galactosidase proteins into retrovirus particles.

Authors:  T A Jones; G Blaug; M Hansen; E Barklis
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

5.  Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO.

Authors:  T A Jones
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

6.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

7.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

8.  Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity.

Authors:  I Katoh; Y Yoshinaka; A Rein; M Shibuya; T Odaka; S Oroszlan
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

9.  Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence.

Authors:  R J Gorelick; L E Henderson; J P Hanser; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.

Authors:  Y C Yang; A B Ciarletta; P A Temple; M P Chung; S Kovacic; J S Witek-Giannotti; A C Leary; R Kriz; R E Donahue; G G Wong
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

View more
  22 in total

1.  Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli.

Authors:  Milan V Nermut; Patrick Bron; Daniel Thomas; Michaela Rumlova; Tomas Ruml; Eric Hunter
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Quantitative evaluation of the lengths of homobifunctional protein cross-linking reagents used as molecular rulers.

Authors:  N S Green; E Reisler; K N Houk
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

3.  Hantavirus nucleocapsid protein oligomerization.

Authors:  A Alfadhli; Z Love; B Arvidson; J Seeds; J Willey; E Barklis
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Structural analysis of membrane-bound retrovirus capsid proteins.

Authors:  E Barklis; J McDermott; S Wilkens; E Schabtach; M F Schmid; S Fuller; S Karanjia; Z Love; R Jones; Y Rui; X Zhao; D Thompson
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

5.  Effects of Gag mutation and processing on retroviral dimeric RNA maturation.

Authors:  William Fu; Que Dang; Kunio Nagashima; Eric O Freed; Vinay K Pathak; Wei-Shau Hu
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Analysis of human immunodeficiency virus matrix domain replacements.

Authors:  Isabel Scholz; Amelia Still; Tenzin Choesang Dhenub; Kelsey Coday; Mike Webb; Eric Barklis
Journal:  Virology       Date:  2007-11-08       Impact factor: 3.616

7.  Atomic force microscopy and electron microscopy analysis of retrovirus Gag proteins assembled in vitro on lipid bilayers.

Authors:  G Zuber; E Barklis
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

8.  Assembly of retrovirus capsid-nucleocapsid proteins in the presence of membranes or RNA.

Authors:  G Zuber; J McDermott; S Karanjia; W Zhao; M F Schmid; E Barklis
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

9.  Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.

Authors:  Ayna Alfadhli; Andrew Mack; Logan Harper; Sam Berk; Christopher Ritchie; Eric Barklis
Journal:  Bioorg Med Chem       Date:  2016-09-12       Impact factor: 3.641

10.  Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane association.

Authors:  Mariam Andrawiss; Yasuhiro Takeuchi; Lindsay Hewlett; Mary Collins
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.